辻本 正和

Purpose ¹⁷⁷ Lu-DOTATATE-targeted radionuclide therapy (TRT) is effective for patients with somatostatin receptor (SSTR)-positive neuroendocrine tumors; however, radiation safety regulations often necessitate hospitalization, particularly in countries with stringent discharge criteria. This study aimed to identify pretreatment factors predicting outpatient eligibility. Methods We retrospectively analyzed 26 patients who underwent their first cycle of ¹⁷⁷ Lu-DOTATATE TRT with complete data for analysis. The external dose rate at 1 m (EDR-1 m) was measured 6 h after administration. Patients were divided into two groups: EDR-1 m greater than or equal to 18 μSv/h and less than 18 μSv/h. Characteristics, including age, sex, BMI, body surface area, estimated glomerular filtration rate, administered dose, and tumor site, were compared. In addition, the whole-body washout rate from pretreatment SSTR imaging was evaluated as a potential predictor. Logistic regression and receiver operating characteristic (ROC) analyses were conducted. Results Fourteen of the 26 (53.8%) patients met the discharge criterion at 6 h. No significant differences were observed in demographic or clinical characteristics between groups. The median washout rate was significantly higher in those meeting the criterion (57.6 vs. 35.0%; P  < 0.001). The area under the ROC curve for the washout rate was 0.929, indicating excellent predictive ability. An optimal cut-off value of 53.5% predicted same-day discharge with a sensitivity of 92.9% and specificity of 91.7%. Conclusion The whole-body washout rate derived from pretreatment SSTR imaging is a strong, practical predictor for outpatient eligibility following ¹⁷⁷ Lu-DOTATATE TRT. Incorporating this simple, noninvasive marker into clinical workflow could support individualized discharge planning and improve patient access under strict radiation safety regulations.

This study aimed to determine the optimal measurement conditions for accurate standardized uptake value (SUV) analysis of iodine-123 metaiodobenzylguanidine (¹²³I-MIBG) by examining the relationship between image convergence and quantitation. Single-photon emission computed tomography/computed tomography images were acquired using JS-10 and National Electrical Manufacturers Association (NEMA) body phantoms, with acquisition time per view varied (10, 30, 50, and 100 s/view). Image reconstruction was performed using three-dimensional-ordered subset expectation maximization, adjusting the product of subset and iteration (SI product; 60, 120, 180) and Gaussian filter parameters (8, 10, 12 mm). For the JS-10 phantom, we evaluated the dose linearity (DL), the recovery coefficient (RC) of individual rods, the scatter ratio (SR), and the coefficient of variation (CV). For the NEMA body phantom, we assessed the contrast-to-noise ratio (CNR) of the 17-mm-diameter hot sphere. We also evaluated the maximum and mean SUVs for all its hot spheres, and their relative standard error (RSE), using SUVs obtained at 100 s/view as reference. In the JS-10 phantom, the DL remained stable under all conditions. The RC decreased when the Gaussian filter was large and the SI product was small. A trade-off between the CV and the SR emerged, depending on the acquisition time and the SI product; optimal results were observed at 50 − 100 s/view and an SI product of 120 − 180. In the NEMA body phantom, contrast improved with acquisition times of ≥30 s/view, and the CNR increased as noise declined with longer acquisition times. At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. In conclusion, accurate SUV measurement with ¹²³I-MIBG requires an acquisition time of ≥50 s/view, an SI product of approximately 120, and a Gaussian filter of 10 − 12 mm. These findings provide a foundation for future studies comparing this method with the heart-to-mediastinum ratio, supporting its clinical application.

Abstract Background Cardiac amyloidosis requires quantitative assessment using technetium-99m pyrophosphate (^99mTc-PYP) single-photon emission computed tomography (SPECT)/computed tomography (CT) for adequate discrimination and evaluation of disease extent. This study aimed to evaluate the utility of standardized uptake value (SUV) analysis using ^99mTc-PYP SPECT/CT in pathologically-confirmed transthyretin amyloid cardiomyopathy (ATTR-CM). The study also explored the relationship between local uptake heterogeneity and indicators of cardiac impairment. Methods Forty patients diagnosed via heart biopsy and genetic analysis (20 ATTR-CM; 4 light-chain amyloidosis, 16 non-amyloidosis) were enrolled. The mean SUVs of the heart and aorta were measured using SPECT images. Discrimination performance was evaluated by comparing each SUV, the heart-to-aorta ratio (rSUV_H/Ao), and the heart-to-contralateral-lung ratio with pathological findings serving as the gold standard. Polar maps were analyzed to assess local SUV distribution in patients with ATTR-CM. The coefficient of variation (COV) of myocardial uptake, difference score between the septum and lateral wall (%DS), base-to-apex variability, and total cardiac SUV were calculated and compared with echocardiographic parameters. Results All metrics were significantly different between the ATTR-CM and non-amyloidosis groups. The rSUV_H/Ao effectively differentiated patients with ATTR-CM from those with light-chain or non-amyloidosis. Local myocardial SUV distribution correlated with impaired cardiac function. Notably, COV showed significant correlations with e' (R = 0.782) and E/e' (R =  − 0.625), linking heterogeneity to myocardial stiffness and diastolic dysfunction. Larger %DS, which predominantly reflected the ATTR-CM pattern of high septal uptake, correlated significantly with thinner walls (average wall thickness, R =  − 0.655; relative wall thickness, R =  − 0.486). As the total cardiac SUV increased, the %DS decreased (reflecting more homogeneous distribution), and global longitudinal strain worsened (R = 0.614). These observations indicated that greater impairment was associated with a higher disease burden. Conclusions This study demonstrated that quantitative SPECT analysis provides a valuable tool for the diagnostic evaluation and differentiation of ATTR-CM. The rSUV_H/Ao offers high discriminatory performance. Local heterogeneity and total myocardial uptake are closely related to the disease burden and extent, as reflected by structural and functional abnormalities on echocardiography. These findings suggest potential relevance to the non-invasive assessment of these aspects of the disease at a single time point. Graphical abstract